Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.

PT150 is a clinical-stage molecule, taken orally, with a strong safety profile having completed Phase 1 and Phase 2 clinical trials for its original use as an antidepressant. It has an active IND for COVID-19. Antiviral activities have been found for PT150 and other members of its class in a variety...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Cycle
Main Authors: Theise, Neil D., Arment, Anthony R., Chakravarty, Dimple, Gregg, John M. H., Jacobson, Ira M., Jung, Kie Hoon, Nair, Sujit S., Tewari, Ashutosh K., Thurston, Archie W., Van Drie, John, Westover, Jonna B.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738205/
https://ncbi.nlm.nih.gov/pubmed/33305659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1859752
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados